Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

tyrosine/nekros

Länken sparas på Urklipp
13 resultat

Uncatalyzed sigmatropic rearrangement of tyrosine-based compounds

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION Technical Field The present disclosure relates to compounds having a tyrosine-based structure with prenyl group substitution and bearing properties for abrogating TRAIL resistance. A method for producing the compounds, and a pharmaceutical composition comprising one or

Method for making a prenyl group-substituted tyrosine compound

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION Technical Field The present disclosure relates to compounds having a tyrosine-based structure with prenyl group substitution and bearing properties for abrogating TRAIL resistance. A method for producing the compounds, and a pharmaceutical composition comprising one or

Use of sesquiterpene lactones for treatment of severe inflammatory disorders

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This invention pertains to sesquiterpene lactones and sesquiterpene lactone-containing plant extracts and preparations for pharmaceutical uses, particularly the use of sesquiterpene lactones for the treatment of severe inflammatory disorders, for example, sepsis, septic shock, or septicemia. A large

Synthesis of (S)-2-acetamido-3-(4-hydroxy-3-(3-methylbut-2-enyl) phenyl) propanoic acid derivatives

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION Technical Field The present disclosure relates to compounds having a tyrosine-based structure with prenyl group substitution and bearing properties for abrogating TRAIL resistance. A method for producing the compounds, and a pharmaceutical composition comprising one or

Methods of treating cognitive impairment

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION Memory loss has long been recognized as a common accompaniment of aging. The inabilities to recall the name of a recent acquaintance or the contents of a short shopping list are familiar experiences for everyone, and this experience seems to become more common as we

Methods of treating cognitive impairment

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION Memory loss has long been recognized as a common accompaniment of aging. The inabilities to recall the name of a recent acquaintance or the contents of a short shopping list are familiar experiences for everyone, and this experience seems to become more common as we

Methods of treating cognitive impairment

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION Memory loss has long been recognized as a common accompaniment of aging. The inabilities to recall the name of a recent acquaintance or the contents of a short shopping list are familiar experiences for everyone, and this experience seems to become more common as we

Antibody fragment-polymer conjugates and uses of same

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION This application relates to the field of antibody fragments derivatized with polymers, and in particular to the use of such derivatization to increase the circulation half-lives of antibody fragment-polymer conjugates. This application also relates to the use of such antibody

Antibody fragment-polymer conjugates and uses of same

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION This application relates to the field of antibody fragments derivatized with polymers, and in particular to the use of such derivatization to increase the circulation half-lives of antibody fragment-polymer conjugates. This application also relates to the use of such antibody

Antibody fragment-polymer conjugates and uses of same

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION This application relates to the field of antibody fragments derivatized with polymers, and in particular to the use of such derivatization to increase the circulation half-lives of antibody fragment-polymer conjugates. This application also relates to the use of such antibody

Methods of binding TNF-.alpha. using anti-TNF-.alpha. antibody fragment-polymer conjugates

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
THE SEQUENCE LISTING The instant specification contains a sequence listing, hereby incorporated by reference, which was filed with the parent of the present application, U.S. patent application Ser. No. 12/850,490, in paper and in txt format on Dec. 30, 2010, the txt file being 84.6 kB in size. The

Antibody fragment-polymer conjugates and uses of same

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
THE SEQUENCE LISTING Please enter into the specification the computer readable copy of the sequence listing filed with the present application in txt format on Dec. 30, 2010, being 84.6 kB in size. The Sequence Listing includes the sequences identified as SEQ ID NOs: 1 through 72. FIELD OF THE

Antibody fragment-polymer conjugates and uses of same

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION This application relates to the field of antibody fragments derivatized with polymers, and in particular to the use of such derivatization to increase the circulation half-lives of antibody fragment-polymer conjugates. This application also relates to the use of such antibody
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge